NMN for Perimenopause: What the Evidence Actually Shows

By T Dinaiz · BSc Molecular Biology, MSc Biotechnology

Last reviewed 2026-04-28. NMN's evidence base, and Malaysian NPRA/JAKIM/price details, can change - confirm current status with primary sources and a registered doctor before acting.

Why this article exists

Perimenopause is the part of a Malaysian woman’s life that has been quietly underserved for too long. The transition starts somewhere between the late 30s and mid-40s, lasts an average of four to eight years, and ends with the final menstrual period - typically around age 50 to 51 in Southeast Asian women, slightly earlier than the European average reported in older textbooks.

Yet most general practitioners outside teaching hospitals still treat menopause as a single binary event rather than a long, hormonally turbulent process.

Into this gap comes a flood of supplement marketing. NMN sits among the loudest of those voices, often packaged with phrases like “feel young again” or “reverse menopause aging”.

This guide does the opposite. It walks through what NMN can and cannot do for a woman in her 40s or 50s, what the Yoshino 2021 trial actually measured, why HRT is still the evidence-based first line for symptom relief, and how to coordinate everything with a Pakar Sakit Puan in a Malaysian setting.

The perimenopause symptom landscape

Perimenopause is not a single switch. It is a long defrosting of ovarian function during which oestradiol levels swing erratically before settling low. The textbook list of symptoms is familiar but worth restating because Malaysian women often dismiss several of them as “normal stress” or “kerja terlalu banyak”:

• Vasomotor symptoms. Hot flashes and night sweats affect roughly 70-80% of women in the transition. In tropical Malaysia this is doubly difficult - a flash on top of 32°C ambient air can feel unbearable, and it is often the symptom that finally drives a woman to her doctor.
• Sleep disruption. Frequent waking, shorter total sleep, and reduced deep-sleep percentage. Poor sleep then amplifies every other symptom on this list.
• Mood changes. Irritability, low mood, new anxiety, sometimes a first-episode depression. The risk of clinical depression genuinely rises in perimenopause; this is not a stereotype.
• Cognitive fog. Word-finding difficulty, slower processing speed, the dreaded “why did I walk into this room” moment. Most of this resolves postmenopause but it is real during the transition.
• Weight gain and central adiposity. Even with unchanged eating, lean mass falls and visceral fat rises as oestrogen drops.
• Bone loss. Bone mineral density declines roughly 1-2% per year in late perimenopause and the first few years postmenopause.
• Genitourinary symptoms. Vaginal dryness, dyspareunia, recurrent urinary tract infections. These respond well to local oestrogen and very poorly to oral supplements.

The Malaysian woman’s perimenopause reality

Three cultural patterns shape how perimenopause unfolds locally and how NMN tends to enter the picture.

Late presentation. Many Malaysian women, particularly those in their 40s with school-age children and ageing parents, deprioritise their own appointments. By the time they see a Pakar Sakit Puan, symptoms have been running for two or three years. A 2023 audit at Hospital Kuala Lumpur’s menopause clinic found a median symptom duration of 28 months before first specialist consultation.

Cultural reluctance to discuss it. Conversations about night sweats, libido, and vaginal dryness are still rare in extended-family settings. Sisters and friends share recipes for masak lemak more readily than they share notes on hot flashes. This silence delays help-seeking.

Reliance on traditional remedies first. Kacip Fatimah, Manjakani, and various campur-aduk tonics are often tried first, sometimes for years, before a woman visits a doctor. None of these have evidence packages comparable to HRT, and some Manjakani products have been adulterated with corticosteroids in past NPRA seizures.

Heavy supplement marketing. Direct-selling channels and Instagram pharmacists push NMN, collagen, NAD+ patches, and stem-cell-themed products particularly hard at this demographic. The promise of “anti-ageing” lands when the body is visibly changing. This makes critical reading of evidence particularly important.

Yoshino 2021 in detail: why this trial matters for perimenopausal readers

If there is one human NMN trial perimenopausal women should know, it is Yoshino et al., published in Science in 2021. The trial enrolled 25 postmenopausal women with prediabetes (HbA1c 5.7-6.4%) and randomised them to either 250mg of oral NMN daily or placebo for 10 weeks.

The endpoint was muscle insulin sensitivity assessed by hyperinsulinaemic-euglycaemic clamp, which is the gold-standard test in metabolic research - far more sensitive than fasting glucose or HbA1c.

The result: muscle insulin sensitivity improved by roughly 25% in the NMN arm, with no improvement in the placebo arm. Importantly, the trial did not show changes in body weight, fasting glucose, HbA1c, blood pressure or lipid panel over 10 weeks.

The authors framed this honestly: NMN improved a mechanistic intermediate, and longer trials with hard endpoints are still needed.

Why this matters for a Malaysian woman in perimenopause:

• The population studied was post-menopausal, so the hormonal milieu is closer to a Malaysian woman in her late 40s or 50s than to a young athlete.
• Insulin resistance accelerates around the menopausal transition because oestrogen normally supports skeletal-muscle glucose uptake. When oestrogen falls, insulin sensitivity falls with it.
• The 250mg dose used is also the dose with the strongest safety record across other adult trials (Igarashi 2022, Fukamizu 2022).

The Rajman 2018 review remains the best sceptical counterweight. It points out that biomarker improvements like the Yoshino result are not the same as proven prevention of diabetes, fractures, or cardiovascular events. A reasonable reader holds both findings simultaneously: the mechanism is real, the long-term clinical pay-off is still unproven.

What about Fukamizu 2022?

Fukamizu and colleagues ran a 12-week safety-evaluation study in healthy Japanese women aged 30-65 at 250mg/day. No serious adverse events, no clinically meaningful changes in liver enzymes, kidney markers, or full blood count.

This is reassuring for women in our target demographic: a Japanese cohort overlaps reasonably well with Malaysian Chinese and Malaysian Indian metabolic profiles, less so with Malay or Indigenous profiles, but it remains the closest published safety read-out for Asian women specifically.

NMN is not a hormone - say this clearly

A patient sometimes arrives at clinic and says, “I bought NMN to fix my hot flashes.” This is the wrong frame, and it leads to disappointment.

NMN raises NAD+. NAD+ supports sirtuin and PARP enzyme function, which influences mitochondrial biogenesis and DNA-repair signalling. None of this directly affects the hypothalamic thermoregulatory centre that drives a hot flash.

None of it raises oestradiol, progesterone or testosterone. NMN will therefore not eliminate flashes, end night sweats, restore lubrication, or reverse vaginal atrophy.

What NMN may help with - based on current mechanistic and clinical evidence - is the metabolic and energetic axis: muscle insulin sensitivity, mitochondrial efficiency, possibly subjective energy and walking-test performance (Igarashi 2022).

For a woman whose perimenopause is dominated by weight gain, fatigue, and creeping insulin resistance, that axis is meaningful. For a woman whose dominant symptom is hot flashes ten times a day, NMN is the wrong tool.

HRT remains the evidence-based first line

This site does not prescribe HRT and cannot replace your gynaecologist. But the evidence-based picture is straightforward enough to summarise.

Modern menopausal hormone therapy - typically oestradiol with or without micronised progesterone - has decades of randomised trial data. For women under 60 or within 10 years of menopause, the absolute benefits for vasomotor symptoms, bone protection, and quality of life generally outweigh the small absolute risks for most patients without contraindications.

The Women’s Health Initiative scare from 2002 was largely about an older population on now-outdated formulations and has been substantially revised by subsequent re-analyses.

Malaysian gynaecologists at hospitals such as UMMC, Hospital Kuala Lumpur, IJN’s women’s heart programme, KPJ Damansara, Sunway Medical and Pantai Hospital all prescribe HRT routinely when indicated. Out-of-pocket cost ranges roughly RM80-RM250 per month depending on formulation and pharmacy.

If you have hot flashes that wake you nightly, sleep loss that is destroying your work performance, or new mood instability, ask your Pakar Sakit Puan whether HRT is appropriate for you. Then, separately, decide whether NMN belongs alongside it for metabolic support. Do not stack supplements as a substitute for a conversation that should happen.

The metabolic angle: where NMN actually fits

Oestrogen is, among many other things, a metabolic hormone. It supports insulin signalling in muscle, helps regulate hepatic lipid handling, and modulates body fat distribution. When oestrogen falls in late perimenopause, several things happen simultaneously:

• Skeletal muscle becomes more insulin-resistant
• Visceral fat increases at the expense of subcutaneous fat
• LDL cholesterol typically rises, HDL falls
• Fasting glucose creeps up by 0.2-0.4 mmol/L on average
• Risk of new-onset type 2 diabetes climbs noticeably in the years around the final menstrual period

This is exactly the territory Yoshino 2021 addressed. By restoring NAD+, NMN supports SIRT1-mediated improvements in muscle insulin signalling, which is the same axis disrupted by oestrogen decline. The trial result is therefore mechanistically coherent rather than coincidental.

Practically, this means NMN is best framed for perimenopausal women as a metabolic adjunct, not a symptom-relief drug.

Pair it with the lifestyle moves that actually move the needle - resistance training twice a week, 7000-10000 steps a day, a Mediterranean-leaning Asian diet - and consider it a small but evidence-supported tile in your metabolic toolkit.

Foundation supplements that pair well

Before adding NMN, make sure the basics are in place. These are inexpensive, well-evidenced for perimenopausal women, and address gaps NMN does not touch.

• Vitamin D3, 1000-2000 IU/day. Despite our latitude, most Malaysian women working indoors are mildly vitamin-D-insufficient. Vitamin D supports bone, mood, and possibly immune health. Cost is roughly RM20-RM40 per month at any Watsons or Guardian.
• Magnesium glycinate or citrate, 200-400mg in the evening. Helps with sleep quality, occasional muscle cramps, and may modestly reduce migraine frequency for those affected. Roughly RM40-RM70 per month.
• Calcium, 500-1000mg/day total intake including diet. Combined with vitamin D for bone protection. Most women hit part of this through dairy, leafy greens, and small fish; supplementation fills the gap.
• Omega-3 (EPA+DHA), 1-2g/day. Supports mood, joint comfort, and cardiovascular profile. Choose products with third-party oxidation testing - heat-sensitive in a tropical climate.

These four cost less than most NMN products combined and have stronger trial backing for perimenopausal symptoms. Build this foundation first, then layer NMN on top once tolerance and budget allow.

Kacip Fatimah and other traditional remedies

Kacip Fatimah (Labisia pumila) is the most-cited Malaysian traditional remedy for perimenopause. It has a long history of postpartum and menopausal use across the Malay peninsula.

There is some early human research from local universities suggesting modest effects on bone markers and quality-of-life scores, but the trials are small, often unblinded, and use different extracts at different doses. The evidence does not approach what HRT carries.

A reasonable position is this: if you and your gynaecologist agree that Kacip Fatimah is worth trying for cultural and personal reasons, choose a product with a clean GMP audit and a JAKIM halal certification. Do not combine it with phytoestrogen-heavy supplements without telling your doctor, particularly if you have a history of oestrogen-receptor-positive breast disease.

Manjakani (oak gall) is sometimes marketed similarly. It has even less human trial data and has appeared in past NPRA adulteration warnings - verify the seller carefully if you choose to use it.

Treat traditional remedies as their own category, not as a swap for NMN or HRT. Stacking three or four perimenopause products without a clinician’s oversight is how interactions and adulterations cause real harm.

Questions for a perimenopause NMN discussion

Use this as a discussion checklist based on the Yoshino and Igarashi trials, adapted for a Malaysian setting.

Weeks 1-4: Ask whether the 250mg/day trial context is relevant to you. Track sleep, energy, and any hot-flash pattern in a simple notebook or app if your clinician agrees to a trial. Continue any HRT or other prescribed medication unchanged.

Weeks 5-12: If a trial is tolerated and budget allows, ask whether there is any reason to continue, change, or stop. Do not escalate because a webpage or influencer made higher doses sound routine.

Month 3 review: Re-check fasting glucose, HbA1c, lipid panel, and (if relevant) bone-turnover markers with your doctor. If markers have improved or stabilised and you feel better, continue. If nothing has moved and the spend is meaningful, stop without guilt.

Storage. Refrigerate the bottle once opened. Malaysia’s heat and humidity will degrade NMN faster than most product labels admit.

When to stop. New unexplained postmenopausal bleeding, severe mood crisis, suicidal thoughts, planned surgery within two weeks, or starting an unfamiliar prescription should trigger a pause until you have spoken to your doctor.

Choosing a product as a Malaysian woman in this stage

A few characteristics matter more for perimenopausal buyers than for younger NMN consumers.

Capsule shell that is HPMC, not gelatin - this future-proofs against any pork-derived gelatin concerns and survives Malaysian heat slightly better.

JAKIM or recognised foreign halal certification for halal-observant buyers. NMN itself is fermentation-derived and does not have an inherent halal issue, but excipients and capsule shells do.

Certificate of Analysis from an independent lab, ideally showing purity above 99% and confirming absence of heavy metals. Adulterated supplements are over-represented in social-media-marketed products targeting women.

Reasonable price. A 60-capsule, 250mg bottle should cost roughly RM150-RM280 in Malaysia. Anything dramatically cheaper warrants caution; anything dramatically more expensive is rarely justified.

See our brands directory and where to buy guide for current product-level recommendations.

When to escalate

Some symptoms during perimenopause are not “just menopause” and need urgent specialist review. Pause any new supplement, NMN included, and see your Pakar Sakit Puan or nearest hospital if you experience:

• Heavy menstrual bleeding soaking through pads or tampons within an hour, or bleeding lasting more than 7 days
• Any postmenopausal bleeding (after 12 months of no periods)
• New breast lumps, nipple discharge, or skin changes
• Severe mood disturbance, panic attacks, or any suicidal thoughts
• Chest pain, severe headaches, or one-sided weakness
• New pelvic pain that does not resolve

These symptoms have specific differential diagnoses - fibroids, polyps, endometrial hyperplasia or cancer, breast disease, depression with suicidality, cardiovascular events - that no supplement can address.

Bottom line

NMN is not a perimenopause cure. It is not a hormone, it does not stop hot flashes, and it is not a substitute for a conversation with your gynaecologist about HRT.

Based on the Yoshino 2021 trial and the wider mechanistic literature, it is a metabolic supplement question for women in late perimenopause and early postmenopause, particularly those whose dominant concerns are insulin sensitivity, weight, and energy.

If you are considering NMN, bring the 250mg trial context to a doctor/pharmacist discussion. Build the foundation supplements - vitamin D, magnesium, calcium, omega-3 - first where appropriate. Discuss HRT with a Pakar Sakit Puan if vasomotor or mood symptoms are dominant.

Buy from sellers who can show you a lot-specific certificate of analysis, store the bottle in the fridge, and review your bloods on a clinician-agreed schedule. Treat NMN as a small, evidence-informed tile in a much bigger picture, not as the picture itself.